Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReach Plc Regulatory News (RCH)

Share Price Information for Reach Plc (RCH)

Share Price is delayed by 15 minutes
Get Live Data
51.20    -0.10 (-0.19%)
Bid:
51.10
Ask:
51.30
Spread: 0.20 (0.391%)
Market Cap: £161.59m
RCH Live PriceLast checked at - London Stock Exchange

Intraday Reach Plc Share Chart

Director/PDMR Shareholding

30 Mar 2020 16:31

RNS Number : 1035I
Reach PLC
30 March 2020
 

30 March 2020

 

Reach plc (the "Company")

 

Grant of Awards under the Company's Long Term Incentive Plan 2012 ("LTIP")

 

The independent trustee (the "Trustee") of the Company's Employees' Benefit Trust based in Jersey (the "Trust") notified the Company that on 27 March 2020 it granted awards under the LTIP to acquire ordinary shares in the capital of the Company to Persons Discharging Managerial Responsibility ("PDMR") within the Company, in the amounts set out below.

 

Under the terms of the LTIP, Awards will normally vest on the third anniversary of their date of grant subject to the satisfaction of conditions relating to the performance of the Company over the three financial years to which an award relates. Upon vesting, awards are subject to a holding period of a further two years. During the holding period restrictions will apply to the sale or other disposal of the shares. The Awards will also be subject to the malus and clawback provisions of the LTIP.

 

The awards will be subject to achievement of the performance conditions as set out in the Directors' Remuneration Report in the 2019 Annual Report and Accounts.

 

The total exercise price payable on any exercise of an LTIP award is £1. Nothing is paid for the grant of the Award.

 

The base price for calculating the level of award was 96.9p, the average market closing price between 24 and 26 March 2020.

 

The Reach share price has trended lower recently due to various global factors, which are not considered to be specific to the Company. Under the rules of the LTIP the Remuneration Committee has discretion to direct the Trustee to moderate vesting levels to ensure that the final outcomes are appropriate based on the performance of the Company and in light of any relevant factors (including any windfall gains).

 

Details of the transactions are set out below:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jim Mullen

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Reach plc

b)

 

LEI

 

 

213800GNI5XF3XOATR61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p Shares

Identification code

GB0009039941

b)

 

Nature of the transaction

 

 

Grant of share options under the Company's Long Term Incentive Plan 2012.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£nil

750,258

d)

 

Aggregated information

- Aggregated volume

750,258

- Price

nil

e)

 

Date of the transaction

 

 

27 March 2020

f)

 

Place of the transaction

 

 

XLON

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Simon Fuller

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Reach plc

b)

 

LEI

 

 

213800GNI5XF3XOATR61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p Shares

Identification code

GB0009039941

b)

 

Nature of the transaction

 

 

Grant of share options under the Company's Long Term Incentive Plan 2012.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£nil

468,272

d)

 

Aggregated information

- Aggregated volume

468,272

- Price

nil

e)

 

Date of the transaction

 

 

27 March 2020

f)

 

Place of the transaction

 

 

XLON

 

 

 

 

Enquiries

Reach

020 7293 3000

Jim Mullen, Chief Executive Officer

Simon Fuller, Chief Financial Officer

Lorraine Clover, Group Company Secretary

 

Tulchan Communications

020 7353 4200

David Allchurch, Partner

LEI: 213800GNI5XF3XOATR61

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEBLFXBXLBBBB
Date   Source Headline
22nd Apr 201510:42 amRNSHolding(s) in Company
27th Mar 201510:35 amRNSNotice of AGM
24th Mar 20159:40 amRNSHolding(s) in Company
17th Mar 20159:27 amRNSResponse to media speculation
16th Mar 20151:28 pmRNSDirector/PDMR Shareholding
16th Mar 20151:28 pmRNSDirector/PDMR Shareholding
10th Mar 201511:45 amRNSDirector/PDMR Shareholding
4th Mar 20153:35 pmRNSDirector/PDMR Shareholding
2nd Mar 201510:38 amRNSReplacement announcement Annual Report 2014
2nd Mar 20159:44 amRNSDirectorate Change
2nd Mar 20159:42 amRNSAnnual Report 2014
2nd Mar 20157:00 amRNSAnnual Results for 52 weeks ended 28 December 2014
13th Feb 20157:00 amRNSTrading Update
2nd Feb 201512:11 pmRNSHolding(s) in Company
16th Jan 20154:12 pmRNSCompany Secretary Change
12th Dec 20145:51 pmRNSDirectorate Change
17th Nov 20142:23 pmRNSDirectorate Change
10th Nov 20147:00 amRNSInterim Management Statement
5th Nov 20147:00 amRNSDirectorate Change
24th Sep 20149:00 amRNSHistorical Legal Issues
18th Sep 20145:02 pmRNSHolding(s) in Company
5th Aug 201412:00 pmRNSDirectorate Change
31st Jul 201410:37 amRNSDirector/PDMR Shareholding
28th Jul 20147:00 amRNSHalf Yearly Report
14th Jul 20142:17 pmRNSHolding(s) in Company
3rd Jul 201411:56 amRNSHolding(s) in Company
26th Jun 20143:54 pmRNSHolding(s) in Company
20th Jun 201411:03 amRNSHolding(s) in Company
9th Jun 20142:11 pmRNSDirector Declaration
22nd May 20143:35 pmRNSDirector/PDMR Shareholding
20th May 201412:58 pmRNSDirector/PDMR Shareholding
15th May 20142:54 pmRNSResult of AGM
15th May 20147:00 amRNSInterim Management Statement
2nd May 201410:23 amRNSCapital Reduction
17th Apr 20145:59 pmRNSHolding(s) in Company
8th Apr 201411:47 amRNSNotice of AGM
3rd Apr 201410:37 amRNSHolding(s) in Company
28th Mar 20142:38 pmRNSResults of General Meeting
20th Mar 20147:00 amRNSDirector/PDMR Shareholding
20th Mar 20147:00 amRNSDirector/PDMR Shareholding
14th Mar 20141:52 pmRNSDirector/PDMR Shareholding
13th Mar 20147:00 amRNSAnnual Report and Accounts
13th Mar 20147:00 amRNSAnnual Results for 52 weeks ended 29 December 2013
12th Mar 20147:00 amRNSNotice of General Meeting
17th Feb 201410:15 amRNSHolding(s) in Company
17th Feb 20149:46 amRNSHolding(s) in Company
6th Feb 20144:11 pmRNSHolding(s) in Company
4th Feb 20147:00 amRNS2013 Profit Upgrade and Impairment
3rd Feb 20144:14 pmRNSHolding(s) in Company
3rd Feb 20148:51 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.